DEA Turns Down Cannabis Business Registrations in Several States

A busy day in cannabis policy centers on the Drug Enforcement Administration, which has rejected cannabis business registrations in multiple states. The development matters because those registrations are tied to the federal rescheduling process, and companies that were hoping to gain federal standing are learning that not every application will be approved. Beyond the DEA news, the day's roundup touches on several other threads that could shape the policy landscape. Republican leaders in Congress who are opposed to marijuana reform are drawing attention as lawmakers sort out leadership for the coming session, raising questions about how receptive Capitol Hill will be to changes in cannabis law. A Senate panel's stances on both cannabis and psychedelics are also in focus, offering a look at where members of that committee stand on two issues that often move on parallel tracks. Closer to the states, there is word of bipartisan teamwork on cannabis in Texas, where officials from both parties are signaling a willingness to cooperate. And in Iowa, the governor-elect has weighed in on the question of legalization, a topic that has been slow to gain traction in the state. Taken together, the items show how much of cannabis policy depends on several levels of government at once, from federal agencies deciding who qualifies for new protections, to Congress deciding whether to support or block reform, to state leaders deciding how far to go. For businesses, the DEA decisions are the most immediate concern, since they affect who can operate with the benefit of federal recognition. For advocates and consumers, the political developments are a reminder that changes in leadership and shifting alliances can quickly open or close doors. The pace of news suggests that the coming months will bring more decisions with real consequences for the industry.